These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14686722)

  • 1. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries.
    Brandsaeter B; Friman S; Broomé U; Isoniemi H; Olausson M; Bäckman L; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Kirkegaard P; Bjøro K
    Scand J Gastroenterol; 2003 Nov; 38(11):1176-83. PubMed ID: 14686722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list.
    Brandsaeter B; Broomé U; Isoniemi H; Friman S; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Olsson R; Olausson M; Kirkegaard P; Bjøro K
    Liver Transpl; 2003 Sep; 9(9):961-9. PubMed ID: 12942458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.
    Brandsaeter B; Isoniemi H; Broomé U; Olausson M; Bäckman L; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Kirkegaard P; Friman S; Bjøro K
    J Hepatol; 2004 May; 40(5):815-22. PubMed ID: 15094230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results.
    Bjøro K; Friman S; Höckerstedt K; Kirkegaard P; Keiding S; Schrumpf E; Olausson M; Oksanen A; Isoniemi H; Hjortrup A; Bergan A; Ericzon BG
    Scand J Gastroenterol; 1999 Jul; 34(7):714-22. PubMed ID: 10466884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome.
    Strasser S; Sheil AG; Gallagher ND; Waugh R; McCaughan GW
    J Gastroenterol Hepatol; 1993; 8(3):238-43. PubMed ID: 8518394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
    J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study.
    Lindström L; Jørgensen KK; Boberg KM; Castedal M; Rasmussen A; Rostved AA; Isoniemi H; Bottai M; Bergquist A
    Scand J Gastroenterol; 2018 Mar; 53(3):297-304. PubMed ID: 29301479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients.
    Nordenvall C; Olén O; Nilsson PJ; von Seth E; Ekbom A; Bottai M; Myrelid P; Bergquist A
    Aliment Pharmacol Ther; 2018 Jan; 47(2):238-245. PubMed ID: 29064110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
    Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
    Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waitlist mortality and post-transplant survival in patients with cholestatic liver disease - Impact of changes in allocation policy.
    Staufer K; Kivaranovic D; Rasoul-Rockenschaub S; Soliman T; Trauner M; Berlakovich G
    HPB (Oxford); 2018 Oct; 20(10):916-924. PubMed ID: 29937419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.
    Brandsaeter B; Schrumpf E; Bentdal O; Brabrand K; Smith HJ; Abildgaard A; Clausen OP; Bjoro K
    Liver Transpl; 2005 Nov; 11(11):1361-9. PubMed ID: 16184522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
    Graziadei IW; Wiesner RH; Marotta PJ; Porayko MK; Hay JE; Charlton MR; Poterucha JJ; Rosen CB; Gores GJ; LaRusso NF; Krom RA
    Hepatology; 1999 Nov; 30(5):1121-7. PubMed ID: 10534330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience.
    Emek E; Serin A; Sahin T; Yazici P; Yuzer Y; Tokat Y; Bozkurt B
    Transplant Proc; 2019 Sep; 51(7):2439-2441. PubMed ID: 31405746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.
    Henson JB; Patel YA; King LY; Zheng J; Chow SC; Muir AJ
    Liver Transpl; 2017 Jun; 23(6):769-780. PubMed ID: 28027592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list-a retrospective study.
    Goet JC; Hansen BE; Tieleman M; van Hoek B; van den Berg AP; Polak WG; Dubbeld J; Porte RJ; Konijn-Janssen C; de Man RA; Metselaar HJ; de Vries AC
    Transpl Int; 2018 Jun; 31(6):590-599. PubMed ID: 29150966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
    Wiesner RH
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.